Nicotine lowers the secretion of the Alzheimer's amyloid β-protein precursor that contains amyloid β-peptide in rat

Reports of an inverse relationship between nicotine intake, due to cigarette smoking, and the incidence of Alzheimer's disease (AD) prompted us to investigate the effects of nicotine on amyloid β-protein precursor (AβPP) processing in rat. Over-production and/or altered metabolism of AβPP, resu...

Full description

Saved in:
Bibliographic Details
Published inJournal of Alzheimer's disease Vol. 4; no. 5; pp. 405 - 415
Main Authors Utsuki, Tadanobu, Shoaib, Mohammed, Holloway, Harold W., Ingram, Donald K., Wallace, William C., Haroutunian, Vahram, Sambamurti, Kumar, Lahiri, Debomoy K., Greig, Nigel H.
Format Journal Article
LanguageEnglish
Published London, England SAGE Publications 01.10.2002
Subjects
Online AccessGet full text
ISSN1387-2877
1875-8908
DOI10.3233/JAD-2002-4507

Cover

Loading…
More Information
Summary:Reports of an inverse relationship between nicotine intake, due to cigarette smoking, and the incidence of Alzheimer's disease (AD) prompted us to investigate the effects of nicotine on amyloid β-protein precursor (AβPP) processing in rat. Over-production and/or altered metabolism of AβPP, resulting in increased amyloid β-peptide (Aβ), appear pivotal in the pathogenesis of AD. Aβ is generated proteolytically from βPP by a group of secretases. AβPP cleavage by γ-secretase results in the secretion of a truncated soluble βPP (sAPPγ) that contains intact Aβ. Nicotine, 1 and 8 mg/kg/day, doses commensurate with cigarette smoking and a higher but well tolerated dose, respectively, was administered over 14 days and Western blot analysis was performed on sAPP fragments. Both doses significantly reduced sAPPγ. These actions were blocked by nicotinic receptor antagonism. Whereas nicotinic antagonists alone had no effect on either total sAPP or sAPPγlevels in CSF, muscarinic antagonism significantly elevated them; suggesting that muscarinic rather than nicotinic receptor silence alters processing of AβPP to favor a potentially amyloidogenic route. Combined nicotine and muscarinic antagonism attenuated the action of the latter to elevate sAPPγ, indicating that nicotine modifies AβPP processing away from potentially amyloidogenic products. These results suggest that within the brain, levels of total sAPP, sAPPγ and, accordingly, Aβ are subject to cholinergic manipulation, offering therapeutic potential at the level of AβPP processing to decrease Aβdeposition.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:1387-2877
1875-8908
DOI:10.3233/JAD-2002-4507